Arzoxifene hydrochloride clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 1998
How each study uses arzoxifene hydrochloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- arzoxifene hydrochloride
- 4
Studies by the year they started
4 studies that test it; most in 1998 (3)
| Year | Studies |
|---|---|
| 1998 | 3 |
| 2002 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 2
Eli Lilly and Company (2) · Memorial Sloan Kettering Cancer Center (1) · The Cleveland Clinic (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses arzoxifene hydrochloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Hormone Therapy in Treating Women With Breast CancerCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00003428Written as arzoxifene hydrochloride
- Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial CancerCompletedPhase 2Eli Lilly and CompanyNCT00003669Written as arzoxifene hydrochloride
- Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal CancerCompletedPhase 2Eli Lilly and CompanyNCT00003670Written as arzoxifene hydrochloride
- Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast CancerCompletedPhase 2The Cleveland ClinicNCT00253539Written as arzoxifene hydrochloride
Codes
What other systems call arzoxifene hydrochloride · ClinicalTrials.gg INT016595
- UNII (FDA) FU88PI0433ARZOXIFENE HYDROCHLORIDEConfirmed FDA, Wikidata
- Wikidata Q27278209arzoxifene hydrochlorideConfirmed FDA, Wikidata
- NCI Thesaurus C2460Arzoxifene HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | FU88PI0433 | ARZOXIFENE HYDROCHLORIDE | Confirmed FDA, Wikidata |
| Wikidata | Q27278209 | arzoxifene hydrochloride | Confirmed FDA, Wikidata |
| NCI Thesaurus | C2460 | Arzoxifene Hydrochloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.